← All trials
NCT00559026
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2004
- Primary completion
- —
- Completion date
- Sep 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Istituto Superiore di SanitàLead sponsor
- ISTITUTO REGINA ELENAOverall official - principal investigator
- ISTITUTO REGINA ELENACollaborator
- University of Rome Tor VergataOverall official - principal investigator
- Istituto Superiore di SanitàStudy director
- University of Rome Tor VergataCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.